Table 5.
Prevalence of anaemia in different age groups of patients attending CAMEF during the in vivo study, 2007-2008, during followup after treatment with Malartin and SP.
| Age group (years) | Number of anaemic cases (%) | |||
|---|---|---|---|---|
| Day 0 | Day 3 | Day 7 | Day 14 | |
| 1–5 N = 49 | 22 (44.90) | 18 (36.73) | 13 (26.53) | 10 (20.41) |
| 6–10 N = 33 | 06 (18.18) | 05 (15.15) | 03 (9.09) | 01 (3.03) |
| 11–15 N = 24 | 06 (25.00) | 03 (12.50) | 02 (8.33) | 03 (12.50) |
| >15 N = 68 | 06 (8.82) | 5 (7.35) | 04 (5.88) | 03 (4.41) |
| Total N = 174 | 40 (22.99) | 31 (17.82) | 22 (12.64) | 17 (9.77) |
| Level of significance |
χ
2 = 21.48, P < 0.001 |
χ
2 = 17.69, P = 0.001 |
χ
2 = 12.15, P = 0.016 |
χ
2 = 10.41, P = 0.034 |